TransMedics Group, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| TMDX | AVR | ITGR | HAE | BBNX | BVS | |
|---|---|---|---|---|---|---|
| Market cap | 2.71B | 648.10M | 4.30B | 5.55B | 963.48M | 924.17M |
| P/E (TTM) | 20.3 | — | 34.6 | 59.0 | — | 17.3 |
| Forward P/E | 34.7 | -6.1 | 18.4 | 21.0 | -7.7 | 14.7 |
| Price/book | 5.2 | 2.6 | 2.5 | 6.6 | 3.1 | 4.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −30.29% | +45.51% | +24.01% | +136.25% | −20.05% | +98.86% |
| Today | +0.39% | −1.77% | −0.07% | +2.84% | +1.30% | +3.56% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All TMDX news ›Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS). TD Cowen analyst Josh Jennings maintained a Buy rating on…
TransMedics Group (NASDAQ:TMDX) Now Covered by Analysts at Barclays
Research analysts at Barclays started coverage on shares of TransMedics Group (NASDAQ:TMDX - Get Free Report) in a research note issued to investors on Wednesday, Briefing.com reports. The brokerage set an "overweight" rating and a $120.00…
Central Pacific Bank Trust Division Purchases 8,417 Shares of TransMedics Group, Inc. $TMDX
Central Pacific Bank Trust Division purchased a new stake in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm…
Law firm investigates Ocugen officers for potential breach of duties to shareholders.
Halper Sadeh LLC is investigating whether Ocugen, Inc. officers and directors breached their fiduciary duties to shareholders. Long-term Ocugen stockholders may seek reforms, financial incentives, or other relief. The law firm offers free…
TransMedics Group Inc (TMDX) Shares Fall 5.8% -- What GF Score o
On October 01, 2026, TransMedics Group Inc TMDX shares fell 5.8%, closing at $78.64. The stock's performance over the past year has been challenging, with a 52-week range between $60.11 and $156.00. GF Value™ is GuruFocus' proprietary…
Is TransMedics Group (NASDAQ:TMDX) Facing a Real Market Test?
McCormick & Company Announces Q3 Fiscal 2026 Results in SEC 8-K Filing A busy session has pulled TransMedics Group into view. The immediate reason is that healthcare names are being judged on adoption, clinical differentiation and…
TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too?
David Weill, a Director at TransMedics Group, Inc. (TMDX -0.24%), purchased 1,336 shares of common stock on Sept. 11, 2026. SEC Form 4 filing Transaction value based on SEC Form 4 weighted average purchase price ($81.63); post-transaction…
TransMedics CFO Fernando N. Araujo Files Initial SEC Ownership Disclosure Reporting No Shares
Kalkine Media Fernando N. Araujo, Chief Financial Officer and Treasurer of TransMedics Group, Inc., submitted a Form 3 Initial Statement of Beneficial Ownership to the SEC on September 29, 2026, indicating no securities beneficially owned…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
kalkinemedia.com2
-
defenseworld.net1
-
fool.com1
-
gurufocus.com1
-
marketbeat.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.